Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Clinical and Experimental Metastasis

• Publication date

  2019-03-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10585-019-09964-3PMID 30915595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of the potential clinical prognostic value of lncRNA-BANCR gene in esophageal squamous cell carcinoma

  2018cited by this paper
• Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes

  2017cited by this paper
• Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer

  2017cited by this paper
• Mechanism of SEMA3B gene silencing and clinical significance in glioma.

  2016cited by this paper
• Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers

  2015cited by this paper
• Analysis of SEMA3B methylation and expression patterns in gastric cancer tissue and cell lines.

  2014cited by this paper
• Identification of genomic alterations in oesophageal squamous cell cancer

  2014cited by this paper
• Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma

  2014cited by this paper
• Loss of CDCP1 Expression Promotes Invasiveness and Poor Prognosis in Esophageal Squamous Cell Carcinoma

  2014cited by this paper
• Non-Coding RNAs and Cancer

  2013cited by this paper
• Gene regulation by antisense transcription

  2013cited by this paper
• Oesophageal carcinoma.

  2013influential reference
• Long non-coding RNAs and their implications in cancer epigenetics

  2013cited by this paper
• DNA extraction from fresh-frozen and formalin-fixed, paraffinembedded human brain tissue

  2013cited by this paper
• Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma.

  2012cited by this paper
• Epidemiology of gastrointestinal and liver tumors.

  2010cited by this paper
• Genetic Heterogeneity of Oesophageal Cancer in High-Incidence Areas of Southern and Northern China

  2010cited by this paper
• Non‐coding RNAs: regulators of disease

  2010cited by this paper
• MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA.

  2010cited by this paper
• Aberrant CpG Island Hypermethylation of RASSF1A in Gastric Cardia Adenocarcinoma

  2009cited by this paper
• Role of Class 3 Semaphorins and Their Receptors in Tumor Growth and Angiogenesis

  2009cited by this paper
• Two CpG islands in the SEMA3B gene: Methylation in clear cell renal cell carcinoma

  2009cited by this paper
• Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells.

  2008cited by this paper
• Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.

  2007cited by this paper
• Epidemiology of oesophagogastric cancer

  2007cited by this paper
• The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer.

  2007cited by this paper
• Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas.

  2006cited by this paper
• Spreading of methylation within RUNX3 CpG island in gastric cancer

  2006cited by this paper
• RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer

  2005cited by this paper
• Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.

  2005cited by this paper
• Aberrant promoter methylation of p16INK4a, RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer

  2005cited by this paper
• Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia

  2005cited by this paper
• Critical Role of Histone Methylation in Tumor Suppressor Gene Silencing in Colorectal Cancer

  2003cited by this paper
• Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.

  2003cited by this paper
• DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer

  2001cited by this paper
• Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

  1999cited by this paper
• Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones.

  1993cited by this paper

• Advances in semaphorin 3B research in tumors (Review)

  2026cites this paper
• Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma and its Clinical Implications in Systemic Chemotherapy

  2025cites this paper
• From genes to survival: A novel cholesterol-based risk model for osteosarcoma

  2025cites this paper
• High methylation of the same promoter of lncRNA ZNF582-AS1/ZNF582 promotes malignant progression of esophageal cancer.

  2024cites this paper
• SEMA3B inhibits TGFβ-induced extracellular matrix protein production and its reduced levels are associated with a decline in lung function in IPF

  2024cites this paper
• Single Nucleotide Polymorphisms [SNPs] in the Shadows: Uncovering their Function in Non-Coding Region of Esophageal Cancer.

  2024cites this paper
• Ten Hypermethylated lncRNA Genes Are Specifically Involved in the Initiation, Progression, and Lymphatic and Peritoneal Metastasis of Epithelial Ovarian Cancer

  2024cites this paper
• scDiffCoAM: A complete framework to identify potential biomarkers for esophageal squamous cell carcinoma using scRNA-Seq data analysis

  2024cites this paper
• SEMA3B‐AS1 suppresses colorectal carcinoma progression by inhibiting Semaphorin 3B‐dependent VEGF signaling pathway activation

  2023cites this paper
• lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer

  2023cites this paper
• Mutual interaction of lncRNAs and epigenetics: focusing on cancer

  2023cites this paper
• Emerging roles and mechanisms of semaphorins activity in cancer.

  2023cites this paper
• LncRNA SEMA3B‐AS1 suppresses the tumor‐initiating characteristics of triple negative breast cancer via engaging in MLL4‐mediated H3K4 trimethylation

  2023cites this paper
• Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma

  2023cites this paper
• PTEN regulates expression of its pseudogene in glioblastoma cells in DNA methylation-dependent manner.

  2023cites this paper
• Association between CDH1 methylation and esophageal cancer risk: a meta-analysis and bioinformatics study

  2022cites this paper
• Long Non-Coding RNA in Esophageal Cancer: A Review of Research Progress

  2022cites this paper
• The lncRNA SEMA3B-AS1/HMGB1/FBXW7 Axis Mediates the Peritoneal Metastasis of Gastric Cancer by Regulating BGN Protein Ubiquitination

  2022cites this paper
• A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response

  2022cites this paper
• Downregulation of LINC00886 facilitates epithelial–mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma

  2022cites this paper
• Establishment and Analysis of a Prognostic Model of Autophagy-Related lncRNAs in ESCA

  2022cites this paper
• A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer

  2022cites this paper
• Regulatory Roles of Noncoding RNAs in the Progression of Gastrointestinal Cancers and Health Disparities

  2022cites this paper
• Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response

  2022cites this paper
• Autophagy related long non-coding RNA and breast cancer prognosis analysis and prognostic risk model establishment

  2021cites this paper
• LINC00239 Interacts with C-Myc Promoter-Binding Protein-1 (MBP-1) to Promote Expression of C-Myc in Esophageal Squamous Cell Carcinoma

  2021cites this paper
• Upregulation of cervical carcinoma expressed PCNA regulatory long non-coding RNA promotes esophageal squamous cell carcinoma progression

  2020cites this paper
• Semaphorins in health and disease.

  2020cites this paper
• Identification and validation of stemness-related lncRNA prognostic signature for breast cancer

  2020cites this paper
• Multiomic Analysis of Methylation and Transcriptome Reveals a Novel Signature in Esophageal Cancer

  2020cites this paper
• Cisplatin changes expression of SEMA3B in endometrial cancer.

  2020cites this paper
• SEMA3A Exon 9 Expression Is a Potential Prognostic Marker of Unfavorable Recurrence-Free Survival in Patients with Tongue Squamous Cell Carcinoma

  2020cites this paper
• Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications

  2020cites this paper
• Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma

  2019cites this paper